Ainsworth Sean 4
4 · Ocuphire Pharma, Inc. · Filed Nov 13, 2020
Insider Transaction Report
Form 4
Ainsworth Sean
Director
Transactions
- Award
Stock Option (right to buy)
2020-11-11+5,000→ 5,000 totalExercise: $4.05Exp: 2030-11-11→ Common Stock (5,000 underlying)
Footnotes (1)
- [F1]Vesting in 12 equal monthly increments beginning on November 30, 2020, except for October 31, 2021 when the balance vests.